| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72888-461-01 | 72888-461 | HUMAN PRESCRIPTION DRUG | Oxcarbazepine | Oxcarbazepine | TABLET | ORAL | 20250520 | N/A | ANDA | ANDA207717 | Advagen Pharma Ltd. | OXCARBAZEPINE | 600 mg/1 | 500 TABLET in 1 BOTTLE (72888-461-01) |
| 72888-461-02 | 72888-461 | HUMAN PRESCRIPTION DRUG | Oxcarbazepine | Oxcarbazepine | TABLET | ORAL | 20250520 | N/A | ANDA | ANDA207717 | Advagen Pharma Ltd. | OXCARBAZEPINE | 600 mg/1 | 100 TABLET in 1 BOTTLE (72888-461-02) |
| 72888-462-01 | 72888-462 | HUMAN PRESCRIPTION DRUG | Oxcarbazepine | Oxcarbazepine | TABLET | ORAL | 20250520 | N/A | ANDA | ANDA207717 | Advagen Pharma Ltd. | OXCARBAZEPINE | 150 mg/1 | 100 TABLET in 1 BOTTLE (72888-462-01) |
| 72888-462-02 | 72888-462 | HUMAN PRESCRIPTION DRUG | Oxcarbazepine | Oxcarbazepine | TABLET | ORAL | 20250520 | N/A | ANDA | ANDA207717 | Advagen Pharma Ltd. | OXCARBAZEPINE | 150 mg/1 | 500 TABLET in 1 BOTTLE (72888-462-02) |
| 72888-460-01 | 72888-460 | HUMAN PRESCRIPTION DRUG | Oxcarbazepine | Oxcarbazepine | TABLET | ORAL | 20250520 | N/A | ANDA | ANDA207717 | Advagen Pharma Ltd. | OXCARBAZEPINE | 300 mg/1 | 100 TABLET in 1 BOTTLE (72888-460-01) |
| 72888-460-02 | 72888-460 | HUMAN PRESCRIPTION DRUG | Oxcarbazepine | Oxcarbazepine | TABLET | ORAL | 20250520 | N/A | ANDA | ANDA207717 | Advagen Pharma Ltd. | OXCARBAZEPINE | 300 mg/1 | 500 TABLET in 1 BOTTLE (72888-460-02) |